Trial Profile
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 25 Aug 2015 New trial record